- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-32-0010038

Liford Pharmaceuticals LLP
About Liford Pharmaceuticals LLP
Data last updated:
Liford Pharmaceuticals LLP is a limited liability partnership (LLP) based in Morbi, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 09 January 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAR-5572.
The LLP has a total obligation of contribution of ₹3.5 Cr. It is led by designated partners including Rajkumar Bharatbhai Patel and Manishkumar Gandubhai Kalaria.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Survey No. 103 Paiki 12 / Paiki 2 Near Hyper Clay Art Old Jodhpar Road Village: Lalpar, Morbi, Gujarat, India – 363642.
The LLP is associated with 1 brand: Lifordpharma. As per MCA filings, the LLP has open charges of ₹7.45 Cr and satisfied charges of ₹4.3 Cr on record.
Liford Pharmaceuticals LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-32-0010038).
Company details
Recognitions & Rankings of Liford Pharmaceuticals
Contact details
Liford Pharmaceuticals LLP's registered office is in Morbi, Gujarat.
- Registered AddressSurvey No. 103 Paiki 12 / Paiki 2 Near Hyper Clay Art Old Jodhpar Road Village: Lalpar, Morbi, Gujarat, India – 363642
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Liford Pharmaceuticals operates one associated brand: Lifordpharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Liford produces quality APIs and intermediates for pharmaceutical markets worldwide. | lifordpharma.com |
Financials of Liford Pharmaceuticals LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Liford Pharmaceuticals LLP, buy the company report.
Designated partners of Liford Pharmaceuticals LLP
Liford Pharmaceuticals has 4 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar Bharatbhai Patel | Designated Partner | 09 Jan 2020 | 6 Years 9 Months | Current |
| Manishkumar Gandubhai Kalaria Also directs: Livon Polymers LLP | Designated Partner | 09 Jan 2020 | 6 Years 9 Months | Current |
| Hiteshbhai Gopalbhai Adroja Also directs: Livon Polymers LLP | Designated Partner | 09 Jan 2020 | 6 Years 9 Months | Current |
| Rajeshkumar Gandubhai Kalariya Also directs: Livon Polymers LLP | Designated Partner | 09 Jan 2020 | 6 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jul 2022 | 100602875 | Bank of India | ₹7.45 Cr | Open | |
| 06 Jul 2021 | 100458745 | The Cosmos Co Op Bank Limited | ₹4.3 Cr | Satisfied |
To see the full charge records of Liford Pharmaceuticals LLP, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Liford Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Liford Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Liford Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Liford Pharmaceuticals LLP has 4 designated partner changes on record since 2020: 4 appointments. The latest: Hiteshbhai Gopalbhai Adroja was appointed as Designated Partner on 09 Jan 2020.
Frequently asked questions
Liford Pharmaceuticals is an active limited liability partnership based in Morbi, Gujarat, India. The LLP works in api manufacturers, within the pharma industry. It was incorporated on 09 January 2020 (6+ years old) and is registered under LLPIN AAR-5572.
Liford Pharmaceuticals has 4 current designated partners:
- Rajkumar Bharatbhai Patel - Designated Partner
- Manishkumar Gandubhai Kalaria - Designated Partner
- Hiteshbhai Gopalbhai Adroja - Designated Partner
- Rajeshkumar Gandubhai Kalariya - Designated Partner
The latest financial statements of Liford Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2020 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Liford Pharmaceuticals is AAR-5572. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Liford Pharmaceuticals was incorporated on 09 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Hiteshbhai Gopalbhai Adroja was appointed as Designated Partner on 09 Jan 2020. Manishkumar Gandubhai Kalaria was appointed as Designated Partner on 09 Jan 2020. Rajeshkumar Gandubhai Kalariya was appointed as Designated Partner on 09 Jan 2020. Liford Pharmaceuticals has 4 designated partner changes on record in total.
Yes, Liford Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-32-0010038).
The registered office of Liford Pharmaceuticals is at Survey No. 103 Paiki 12 Paiki 2 Near Hyper Clay Art Old Jodhpar Road Village: Lalpar, Morbi, Gujarat, India – 363642.
Liford Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.
Liford Pharmaceuticals has open charges of ₹7.45 Cr and satisfied charges of ₹4.3 Cr as per latest MCA filings.